Patent details

EP2379522 Title: CRYSTALLINE FORM OF ALOGLIPTIN

Basic Information

Publication number:
EP2379522
PCT Application Number:
EP2009067548
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097840961
PCT Publication Number:
WO2010072680
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CRYSTALLINE FORM OF ALOGLIPTIN
French Title of Invention:
FORME CRISTALLINE D'ALOGLIPTINE
German Title of Invention:
KRISTALLINE FORM VON ALOGLIPTIN
SPC Number:

Dates

Filing date:
18/12/2009
Grant date:
28/02/2018
EP Publication Date:
26/10/2011
PCT Publication Date:
01/07/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/02/2018
EP B1 Publication Date:
28/02/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/12/2018
Expiration date:
18/12/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/02/2018
 
 

Name:
Sandoz AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
LUDESCHER, Johannes
Address:
Austria (AT)

2

Name:
LAUS, Gerhard
Address:
Austria (AT)

3

Name:
WIESER, Josef
Address:
Austria (AT)

Priority

Priority Number:
08172772
Priority Date:
23/12/2008
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
C07D 401/04;

Publication

European Patent Bulletin

Issue number:
201809
Publication date:
28/02/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/04/2019 Outgoing Correspondence 1